About 30,000 Trademarks found for “dishman pharma solutions ag”

"PHARMA"

Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; regulatory submission management, namely, assisting others in preparing and filing applications for new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics with governmental regulatory bodies; providing consulting services in the field of regulatory submission management to companies to assist them with applications for new drug, generic drug, medical device, drug/device combination, biologic, biosimilar, nutraceutical, consumer product or cosmetic approval; interactive record-keeping services for use in risk management and regulatory compliance by insurers and professionals in the medical field; business risk assessment services

Regulatory compliance consulting in the field of prescription drug sampling; tracking and monitoring regulatory requirements in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics for regulatory compliance purposes; regulatory compliance consulting in the field of new drugs, generic drugs, medical devices, drug/device combinations, biologics, biosimilars, nutraceuticals, consumer products or cosmetics

Providing medical information in the field of pharmacovigilance and clinical trials